Wang X - Search Results

1

Discovery of Novel and Selective Adenosine A_2A Receptor Antagonists for Treating Parkinson's Disease through Comparative Structure-Based Virtual Screening.

Tian S, Wang X, Li L, Zhang X, Li Y, Zhu F, Hou T, Zhen X. Tian S, et al. Among authors: wang x. J Chem Inf Model. 2017 Jun 26;57(6):1474-1487. doi: 10.1021/acs.jcim.7b00188. Epub 2017 May 15. J Chem Inf Model. 2017. PMID: 28463561

2

Structural optimization of aminopyrimidine-based CXCR4 antagonists.

Zhu F, Wang Y, Du Q, Ge W, Li Z, Wang X, Fu C, Luo L, Tian S, Ma H, Zheng J, Zhang Y, Sun X, He S, Zhang X. Zhu F, et al. Among authors: wang x, wang y. Eur J Med Chem. 2020 Feb 1;187:111914. doi: 10.1016/j.ejmech.2019.111914. Epub 2019 Nov 26. Eur J Med Chem. 2020. PMID: 31806538

3

Design, Synthesis, and Characterization of Novel CXCR4 Antagonists Featuring Cyclic Amines.

Lin Y, Li Z, Ma H, Wang Y, Wang X, Song S, Zhao L, Wu S, Tian S, Fu C, Luo L, Zhu F, He S, Zheng J, Zhang X. Lin Y, et al. Among authors: wang x, wang y. ChemMedChem. 2020 Jul 3;15(13):1150-1162. doi: 10.1002/cmdc.202000268. Epub 2020 May 29. ChemMedChem. 2020. PMID: 32391652

4

Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists.

Li Z, Wang Y, Fu C, Wang X, Wang JJ, Zhang Y, Zhou D, Zhao Y, Luo L, Ma H, Lu W, Zheng J, Zhang X. Li Z, et al. Among authors: wang x, wang jj, wang y. Eur J Med Chem. 2018 Apr 10;149:30-44. doi: 10.1016/j.ejmech.2018.02.042. Epub 2018 Feb 16. Eur J Med Chem. 2018. PMID: 29494843

5

Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity.

Li Z, Wang X, Lin Y, Wang Y, Wu S, Xia K, Xu C, Ma H, Zheng J, Luo L, Zhu F, He S, Zhang X. Li Z, et al. Among authors: wang x, wang y. Eur J Med Chem. 2020 Nov 1;205:112537. doi: 10.1016/j.ejmech.2020.112537. Epub 2020 Jul 23. Eur J Med Chem. 2020. PMID: 32768738

6

Layer-by-layer assembly for rapid fabrication of thick polymeric films.

Li Y, Wang X, Sun J. Li Y, et al. Among authors: wang x. Chem Soc Rev. 2012 Sep 21;41(18):5998-6009. doi: 10.1039/c2cs35107b. Epub 2012 Jul 16. Chem Soc Rev. 2012. PMID: 22797079

7

Pattern recognition receptor-mediated inflammation in diabetic vascular complications.

Wang X, Antony V, Wang Y, Wu G, Liang G. Wang X, et al. Among authors: wang y. Med Res Rev. 2020 Nov;40(6):2466-2484. doi: 10.1002/med.21711. Epub 2020 Jul 10. Med Res Rev. 2020. PMID: 32648967 Review.

8

Synthesis, bioevaluation and molecular dynamics of pyrrolo-pyridine benzamide derivatives as potential antitumor agents in vitro and in vivo.

Zhang J, Dai J, Lan X, Zhao Y, Yang F, Zhang H, Tang S, Liang G, Wang X, Tang Q. Zhang J, et al. Among authors: wang x. Eur J Med Chem. 2022 Apr 5;233:114215. doi: 10.1016/j.ejmech.2022.114215. Epub 2022 Feb 23. Eur J Med Chem. 2022. PMID: 35227978

9

FAK mediates LPS-induced inflammatory lung injury through interacting TAK1 and activating TAK1-NFκB pathway.

Chen X, Zhao Y, Wang X, Lin Y, Zhao W, Wu D, Pan J, Luo W, Wang Y, Liang G. Chen X, et al. Among authors: wang x, wang y. Cell Death Dis. 2022 Jul 8;13(7):589. doi: 10.1038/s41419-022-05046-7. Cell Death Dis. 2022. PMID: 35803916 Free PMC article.

10

Design, synthesis and anticancer evaluation of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 1,8-naphthyridine-3-carboxamide moiety as novel multi-target TKIs.

Chen P, Zhao Y, Zhang J, Duan Y, Dai J, He J, Wang X, Chen X, Chen P, Zhao W, Wang X, Zhuang Z, Yang D, Liang G, Tang Q. Chen P, et al. Among authors: wang x. Bioorg Chem. 2022 Apr;121:105672. doi: 10.1016/j.bioorg.2022.105672. Epub 2022 Feb 18. Bioorg Chem. 2022. PMID: 35202851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,690 results

Search Page

Filters